SCNI Scinai Immunotherapeutics Ltd Total Asset Value of Company
The price action of the aggregate assets of Scinai Immunotherapeutics (SCNI), whose business is based on the development of immune drugs, demonstrates a value of 14.53. While demand for medicine remains stable, sanctions and geopolitics could disrupt raw material logistics. Financial pressure is mounting due to R&D costs in the absence of sales and the risk of clinical trial failure. Meanwhile, the regulator, rather than economic cycles, determines the company's success.
Analytical breakdowns and data insights for company Scinai (SCNI)
- current quotes and average value forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Scinai Immunotherapeutics|SCNI - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio BiondVax Pharmaceuticals|SCNI - Company Aggregate Debts|Debts to Book Capitalization BiondVax Pharmaceuticals|SCNI - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Scinai Immunotherapeutics|Interim Coverage Ratio scinai.com
- net income and valuation multiples indicators:
Fundamental valuation:Scinai Immunotherapeutics
By advancing immunological pharma through partnerships with institutes and laboratories to create nanobodies, Scinai Immunotherapeutics (SCNI) optimizes resources, which is reflected in total assets via ROA. This indicator, calculated inversely through return on equity, measures the overall scale of assets and liabilities, allowing investors to assess the real capacity of the business and avoid overpaying when purchasing the asset at local peaks.
Key competitors
ARGX - Company Total Asset Base|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|SVRA - Aggregate Company Assets|Company Total Asset Base Rigel Corp RIGL|ANAB: Company Total Assets|Cumulative Company Assets astriatx.com|ENGN (enGene) - Company Total Assets|RAPT Therapeutics Inc. (RAPT) - Company Total Asset Base|Aggregate Company Assets Aerovate Therapeutics Inc (JBIO)|Aclaris Therapeutics, Inc - Total Business Assets|Company Total Assets KYTX (Kyverna Therapeutics)|Company Total Assets tizianalifesciences.com TLSA|Cabaletta Bio - Company Total Assets|Company Total Asset Base Ventyx Biosciences Inc. VTYX|THTX (Theratechnologies Inc) - Cumulative Company Assets|Avalo Therapeutics Inc - Aggregate Asset Value|ELDN (Eledon Pharmaceuticals) - Company Total Assets|agenusbio.com (AGEN) - Company Total Asset Base|Aggregate Company Assets Climb Bio (CLYM)|Cumulative Company Assets Zura Bio Ltd ZURA|Aggregate Company Assets aTyr ATYR|ADAG - Cumulative Company Assets|IMA: Cumulative Company Assets|STTK - Company Total Assets|equilliumbio.com (EQ) - Aggregate Company Assets|Total Business Assets CNTB|Aggregate Company Assets Immunic Therapeutics|Company Assets Atara Biotherapeutics Inc ATRA|Cumulative Company Assets IFRX (InflaRx N.V.)|Aggregate Business Assets XFOR|Company Total Assets ACET (Adicet Bio, Inc.)|Aggregate Asset Value CELU|INmune Bio Corp - Company Total Assets|Company Assets Barinthus Biotherapeutics Corp|Kezar Life Sciences (KZR) - Aggregate Company Assets|sabbiotherapeutics.com - Aggregate Asset Value|AKTX (Akari Therapeutics Plc) - Company Total Assets|Company Total Assets Enlivex Therapeutics, Ltd.|Aggregate Company Assets Q32 Bio Inc. (QTTB)|GOVX: Total Asset Value of Company|Company Total Assets EDSA (Edesa Biotech, Inc.)|ibioinc.com (IBIO) - Company Assets|CARM: Cumulative Company Assets|XTLB - Company Total Assets|BOLT (boltbio.com) - Cumulative Company Assets|HCWB: Aggregate Business Assets|APVO (Aptevo Therapeutics, Inc.) - Company Total Assets|AIM ImmunoTech, Inc. (AIM) - Company Total Asset Base|Company Total Assets ADTX|Cumulative Company Assets GRI Bio Inc GRI|Aggregate Company Assets XORTX XRTX|Company Total Asset Base Vyome Therapeutics (HIND)|REVB - Aggregate Company Assets|Company Total Asset Base indaptusrx.com INDP|CALI: Company Total Assets|Cumulative Company Assets Affimed N.V.|Aggregate Company Assets Allakos Inc|Total Business Assets HOOK (HOOKIPA)|Company Total Assets IGMS|Company Total Asset Base iteostherapeutics.com|Aggregate Company Assets Ocean Biomedical OCEA|TCBP (TC BioPharm (Holdings) Plc) - Total Asset Value of Company|Third Harmonic Bio, Inc - Company Total Assets